- PMID: 34234089
- DOI: 10.1249/JSR.0000000000000858
Abstract
Cannabidiol and other cannabinoids are being used more frequently for sports medicine-related conditions. This review will help sports medicine clinicians answer questions that their athletes and active patients have about the potential effectiveness of cannabinoids on common sports medicine conditions. In the article, the authors compare cannabidiol and delta-9-tetrahydrocannabinol effects, noting the difference on the endocannabinoid and nonendocannabinoid receptors. The theoretical benefits of these two compounds and the current legality in the United States surrounding cannabidiol and delta-9-tetrahydrocannabinol use also are addressed.
Copyright © 2021 by the American College of Sports Medicine.
References
-
- Martin LJ. CBD vs. THC: Properties, Benefits, Risks, & Legality. WebMD. WebMD, 8 Aug. 2019. [cited 2021 May 5]. Available from: www.webmd.com/pain-management/cbd-thc-difference.
-
- Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018; 84:2477–82.
-
- Mecha M, Feliú A, Carrillo-Salinas F, Guaza C. Handbook of Cannabis and Related Pathologies. Elsevier; 2017. p. 893–904.
-
- Iffland K, Grotenhermen F. European Industrial Hemp Association (EIHA) review on: Safety and side effects of cannabidiol—a review of clinical data and relevant animal studies. Hürth (Germany); October 2016. Available from: https://eiha.org/media/2016/10/16-10-24-Safety-and-Side-Effects-of-CBD.pdf.
-
- Lu H-C, Mackie K. An introduction to the endogenous cannabinoid system. Biol. Psychiatry. 2016; 79:516–25.